Last updated 2026-07-20
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
—
About
Thomas Insel, M.D., is a psychiatrist and neuroscientist who has been a national leader in mental health research, policy, and technology. He served as the Director of the National Institute of Mental Health (NIMH) from 2002-2015. Since then, he has co-founded several mental health startups, including Mindstrong Health, Humanest Care, NeuraWell Therapeutics, Vanna Health, Benchmark Health, and AdvocateMH. He is also the author of "Healing: Our Path from Mental Illness to Mental Health." Dr. Insel's work focuses on transforming mental healthcare through innovation, technology, and a focus on "people, place, and purpose" for recovery.
Portfolio
No portfolio companies in this dataset yet.
Investment activity
Portfolio by sector
Health Tech & Life Sciences1
Q&A
- What is Thomas Insel's primary investment focus?
- Thomas Insel primarily focuses on the Health Tech & Life Sciences sector, with all of his known portfolio companies operating in this area.
- Can you name a notable company in Thomas Insel's portfolio?
- A notable company in Thomas Insel's portfolio is Valera Health, which provides comprehensive behavioral health solutions.
- When did Thomas Insel make his most recent disclosed investment?
- Thomas Insel made an investment in November 2021, which was a follow-on round.
- What is the typical investment range for Thomas Insel?
- Thomas Insel's investment range is typically between $3.8 million and $15 million.
- When did Thomas Insel make his first recorded investment?
- Thomas Insel made his first recorded investment in February 2021.
- How many new portfolio companies did Thomas Insel add in 2021?
- Thomas Insel added one new portfolio company in February 2021.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Radar intelligence
Patents
| EPO | 2 |
|---|